Citations (275)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (41)
Seetal Dodd, Michael Bauer, Andre F. Carvalho, Harris Eyre, Maurizio Fava, Siegfried Kasper, Sidney H. Kennedy, Jon-Paul Khoo, Carlos Lopez Jaramillo, Gin S. Malhi, Roger S. McIntyre, Philip B. Mitchell, Angela Marianne Paredes Castro, Aswin Ratheesh, Emanuel Severus, Trisha Suppes, Madhukar H. Trivedi, Michael E. Thase, Lakshmi N. Yatham, Allan H. Young & Michael Berk. (2021) A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don’t work well enough?. The World Journal of Biological Psychiatry 22:7, pages 483-494.
Read now
Read now
. (2019) 11th International Congress on Psychopharmacology & 7th International Symposium on Child and Adolescent Psychopharmacology. Psychiatry and Clinical Psychopharmacology 29:sup1, pages 311-446.
Read now
Read now
Siegfried Kasper. (2019) A thank-you note from the Chief-Editor. The World Journal of Biological Psychiatry 20:4, pages 254-257.
Read now
Read now
Seetal Dodd, Philip B. Mitchell, Michael Bauer, Lakshmi Yatham, Allan H. Young, Sidney H. Kennedy, Lana Williams, Trisha Suppes, Carlos Lopez Jaramillo, Madhukar H. Trivedi, Maurizio Fava, A. John Rush, Roger S. McIntyre, Michael E. Thase, Raymond W. Lam, Emanuel Severus, Siegfried Kasper & Michael Berk. (2018) Monitoring for antidepressant-associated adverse events in the treatment of patients with major depressive disorder: An international consensus statement. The World Journal of Biological Psychiatry 19:5, pages 330-348.
Read now
Read now
Charles South, A John Rush, Thomas J Carmody, Manish K Jha & Madhukar H Trivedi. (2017) Accurately identifying patients who are excellent candidates or unsuitable for a medication: a novel approach. Neuropsychiatric Disease and Treatment 13, pages 3001-3010.
Read now
Read now
Francesco Panza, Madia Lozupone, Eleonora Stella, Lucia Lofano, Carolina Gravina, Maria Urbano, Antonio Daniele, Antonello Bellomo, Giancarlo Logroscino, Antonio Greco & Davide Seripa. (2016) Psychiatry meets pharmacogenetics for the treatment of revolving door patients with psychiatric disorders. Expert Review of Neurotherapeutics 16:12, pages 1357-1369.
Read now
Read now
Arianna Goracci, Rocco N Forgione, Riccardo De Giorgi, Anna Coluccia, Alessandro Cuomo & Andrea Fagiolini. (2016) Practical guidance for prescribing trazodone extended-release in major depression. Expert Opinion on Pharmacotherapy 17:3, pages 433-441.
Read now
Read now
Michael Bauer, Emanuel Severus, Stephan Köhler, Peter C. Whybrow, Jules Angst & Hans-Jürgen Möller. (2015) World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders. Part 2: Maintenance Treatment of Major Depressive Disorder-Update 2015. The World Journal of Biological Psychiatry 16:2, pages 76-95.
Read now
Read now
Chi-Un Pae, Sheng-Min Wang, Soo-Jung Lee, Changsu Han, Ashiwn A Patkar & Prakash S Masand. (2014) Antidepressant and QT interval prolongation, how should we look at this issue? Focus on citalopram. Expert Opinion on Drug Safety 13:2, pages 197-205.
Read now
Read now
Brian Godman, Iain Bishop, Alexander E Finlayson, Stephen Campbell, Hye-Young Kwon & Marion Bennie. (2013) Reforms and initiatives in Scotland in recent years to encourage the prescribing of generic drugs, their influence and implications for other countries. Expert Review of Pharmacoeconomics & Outcomes Research 13:4, pages 469-482.
Read now
Read now
Michael Bauer, Andrea Pfennig, Emanuel Severus, Peter C. Whybrow, Jules Angst & Hans-Jürgen Möller. (2013) World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Update 2013 on the acute and continuation treatment of unipolar depressive disorders. The World Journal of Biological Psychiatry 14:5, pages 334-385.
Read now
Read now
Changsu Han, Sheng-Min Wang, Masaki Kato, Soo-Jung Lee, Ashwin A Patkar, Prakash S Masand & Chi-Un Pae. (2013) Second-generation antipsychotics in the treatment of major depressive disorder: current evidence. Expert Review of Neurotherapeutics 13:7, pages 851-870.
Read now
Read now
Eduard Vieta & Francesc Colom. (2011) Therapeutic options in treatment-resistant depression. Annals of Medicine 43:7, pages 512-530.
Read now
Read now
Chi-Un Pae, Changsu Han & Tae-Youn Jun. (2011) Do we need more than one antidepressant for patients with major depressive disorder?. Expert Review of Neurotherapeutics 11:11, pages 1561-1564.
Read now
Read now
Daniel Souery, Alessandro Serretti, Raffaella Calati, Pierre Oswald, Isabelle Massat, Anastasios Konstantinidis, Sylvie Linotte, Siegfried Kasper, Stuart Montgomery, Joseph Zohar & Julien Mendlewicz. (2011) Citalopram versus desipramine in treatment resistant depression: Effect of continuation or switching strategies. A randomized open study. The World Journal of Biological Psychiatry 12:5, pages 364-375.
Read now
Read now
Susan L McElroy, Anna Guerdjikova, Nicole Mori & Paul E Keck Jr. (2010) Therapeutic potential of new second generation antipsychotics for major depressive disorder. Expert Opinion on Investigational Drugs 19:12, pages 1527-1544.
Read now
Read now
Ulrich Rabl, Christian Scharinger, Markus Müller & Lukas Pezawas. (2010) Imaging genetics: implications for research on variable antidepressant drug response. Expert Review of Clinical Pharmacology 3:4, pages 471-489.
Read now
Read now
Gin S. Malhi, Danielle Adams & Michael Berk. (2009) Is lithium in a class of its own? A brief profile of its clinical use. Australian and New Zealand Journal of Psychiatry 43:12, pages 1096-1104.
Read now
Read now
Hans-Jürgen Möller. (2009) Antidepressants: Controversies about their efficacy in depression, their effect on suicidality and their place in a complex psychiatric treatment approach. The World Journal of Biological Psychiatry 10:3, pages 180-195.
Read now
Read now
Gábor Gazdag, Gábor Sebestyén, Eszter Zsargó, Judit Tolna & Gábor Sándor Ungvari. (2009) Survey of referrals to electroconvulsive therapy in Hungary. The World Journal of Biological Psychiatry 10:4-3, pages 900-904.
Read now
Read now
Cornelius Schüle, Thomas C. Baghai, Daniela Eser, Caroline Nothdurfter & Rainer Rupprecht. (2009) Lithium but not carbamazepine augments antidepressant efficacy of mirtazapine in unipolar depression: An open-label study. The World Journal of Biological Psychiatry 10:4-2, pages 390-399.
Read now
Read now
Alessandro Serretti & Masaki Kato. (2008) The serotonin transporter gene and effectiveness of SSRIs. Expert Review of Neurotherapeutics 8:1, pages 111-120.
Read now
Read now
Borwin Bandelow, Joseph Zohar, Siegfried Kasper & Hans-Jürgen Möller. (2008) How to grade categories of evidence. The World Journal of Biological Psychiatry 9:4, pages 242-247.
Read now
Read now
Michael Soyka, Henry R. Kranzler, Mats Berglund, David Gorelick, Victor Hesselbrock, Bankole A. Johnson, Hans-Jürgen Möller, THE WFSBP TASK FORCE ON TREATMENT GUIDELINES FOR SUBSTANCE USE DISORDERS, Michael Soyka, Henry R. Kranzler, Mats Berglund, David Gorelick, Victor Hesselbrock, Bankole A. Johnson, Hans-Jürgen Möller & THE WFSBP TASK FORCE ON TREATMENT GUIDELINES FOR SUBSTANCE USE DISORDERS. (2008) World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Substance Use and Related Disorders, Part 1: Alcoholism. The World Journal of Biological Psychiatry 9:1, pages 6-23.
Read now
Read now
Ulrich Hegerl, Meike Wittmann, Ella Arensman, Chantal van Audenhove, Jean-Hervé Bouleau, Christina van der Feltz-Cornelis, Ricardo Gusmao, Maria Kopp, Cordula Löhr, Margaret Maxwell, Ulrich Meise, Milan Mirjanic, Högni Oskarsson, Victor Perez Sola, Charles Pull, Roger Pycha, Regula Ricka, Jyrki Tuulari, Airi Värnik & Tim Pfeiffer-Gerschel. (2008) The ‘European Alliance Against Depression (EAAD)’: A multifaceted, community-based action programme against depression and suicidality. The World Journal of Biological Psychiatry 9:1, pages 51-58.
Read now
Read now
Mazda Adli, Katja Wiethoff, Christopher Baethge, Andrea Pfennig, Thomas Stamm & Michael Bauer. (2008) Olanzapine in the treatment of depression with psychotic features: A prospective open-label study. International Journal of Psychiatry in Clinical Practice 12:3, pages 202-209.
Read now
Read now
A. Wade, K. Gembert & I. Florea. (2007) A comparative study of the efficacy of acute and continuation treatment with escitalopram versus duloxetine in patients with major depressive disorder. Current Medical Research and Opinion 23:7, pages 1605-1614.
Read now
Read now
Lars S⊘ndergård, Ana
Garcia Lopez, Per
Kragh Andersen & Lars
Vedel Kessing. (2007) Continued Antidepressant Treatment and Suicide in Patients with Depressive Disorder. Archives of Suicide Research 11:2, pages 163-175.
Read now
Read now
Sabine C. Herpertz, Mary Zanarini, Charles S. Schulz, Larry Siever, Klaus Lieb, Hans-Jürgen Möller, Wfsbp Task Force on Personality Disorders, Sabine C. Herpertz, Mary Zanarini, Charles S. Schulz, Larry Siever, Klaus Lieb, Hans-Jürgen Möller & Wfsbp Task Force on Personality Disorders. (2007) World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Personality Disorders. The World Journal of Biological Psychiatry 8:4, pages 212-244.
Read now
Read now
Michael Bauer, Tom Bschor, Andrea Pfennig, Peter C. Whybrow, Jules Angst, Marcio Versiani, Hans-Jürgen Möller, WFSBP Task Force on Unipolar Depressive Disorders, Michael Bauer, Tom Bschor, Andrea Pfennig, Peter C. Whybrow, Jules Angst, Marcio Versiani, Hans-Jürgen Möller & WFSBP Task Force on Unipolar Depressive Disorders. (2007) World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care. The World Journal of Biological Psychiatry 8:2, pages 67-104.
Read now
Read now
Michael Bauer, Hans-Jürgen Möller & Edith Schneider. (2006) Duloxetine: a new selective and dual-acting antidepressant. Expert Opinion on Pharmacotherapy 7:4, pages 421-427.
Read now
Read now
. (2006) Speaker Abstracts. International Journal of Psychiatry in Clinical Practice 10:4, pages 306-336.
Read now
Read now
Pierre Baumann, Sven Ulrich, Gabriel Eckermann, Manfred Gerlach, Hans-Joachim Kuss, Gerd Laux, Bruno Müller-Oerlinghausen, Marie Luise Rao, Peter Riederer, Gerald Zernig & Christoph Hiemke. (2005) The AGNP-TDM Expert Group Consensus Guidelines: focus on therapeutic monitoring of antidepressants. Dialogues in Clinical Neuroscience 7:3, pages 231-247.
Read now
Read now
Bruno Müller-Oerlinghausen, Werner Felber, Anne Berghöfer, Eric Lauterbach & Bernd Ahrens. (2005) The Impact of Lithium Long-Term Medication on Suicidal Behavior and Mortality of Bipolar Patients. Archives of Suicide Research 9:3, pages 307-319.
Read now
Read now
José L. Ayuso-Gutiérrez. (2005) Depressive subtypes and efficacy of antidepressive pharmacotherapy. The World Journal of Biological Psychiatry 6:sup2, pages 31-37.
Read now
Read now
Saxby Pridmore & Yvonne Turnier-Shea. (2004) Medication options in the treatment of treatment-resistant depression. Australian and New Zealand Journal of Psychiatry 38:4, pages 219-225.
Read now
Read now
Heinz Grunze, Siegfried Kasper, Guy Goodwin, Charles Bowden, David Baldwin, Rasmus W Licht, Eduard Vieta & Hans-Jürgen Möller. (2003) The World Federation of Socleties of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of Mania. The World Journal of Biological Psychiatry 4:1, pages 5-13.
Read now
Read now
. (2003) First aid for a hypertensive crisis. Australian and New Zealand Journal of Psychiatry 37:6, pages 774-775.
Read now
Read now
Michael Bauer & Hans-Jürgen Möller. (2003) Response to letter to the editor from Andrade et al. (2003) ECT in the management of major depression: Implications of recent research, World J Biol Psychiatry 4: 139-140. The World Journal of Biological Psychiatry 4:3, pages 140-141.
Read now
Read now
Chittaranjan Andrade, Alexander I. Nelson & Max Fink. (2003) ECT in the management of major depression: Implications of recent research. The World Journal of Biological Psychiatry 4:3, pages 139-140.
Read now
Read now
Michael Bauer, Peter C. Whybrow, Jules Angst, Marcio Versiani, Hans-Jürgen Möller & WFSBP Task Force on Treatment Guidelines for Unipolar Depressive Disorders. (2002) World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 2: Maintenance Treatment of Major Depressive Disorder and Treatment of Chronic Depressive Disorders and Subthreshold Depressions. The World Journal of Biological Psychiatry 3:2, pages 69-86.
Read now
Read now
Articles from other publishers (234)
Tianyu Wang, Chenjie Gao, Jiaxing Li, Lei Li, Yingying Yue, Xiaoyun Liu, Suzhen Chen, Zhenghua Hou, Yingying Yin, Wenhao Jiang, Zhi Xu, Youyong Kong & Yonggui Yuan. (2023)
Prediction of Early Antidepressant Efficacy in Patients with Major Depressive Disorder Based on Multidimensional Features of rs-fMRI and
P11
Gene DNA Methylation
. The Canadian Journal of Psychiatry.
Crossref
Crossref
Silviya Ralovska, Ivan Koychev, Petar Marinov, Toshi A Furukawa, Benoit Mulsant & Andrea Cipriani. (2023) Brexpiprazole versus placebo or other antidepressive agents for treating depression. Cochrane Database of Systematic Reviews 2023:7.
Crossref
Crossref
Tingting Tan, Zhi Xu, Chenjie Gao, Tian Shen, Lei Li, Zimu Chen, Lei Chen, Min Xu, Bingwei Chen, Jiacheng Liu, Zhijun Zhang & Yonggui Yuan. (2022) Influence and interaction of resting state functional magnetic resonance and tryptophan hydroxylase-2 methylation on short-term antidepressant drug response. BMC Psychiatry 22:1.
Crossref
Crossref
Tianyu Wang, Lei Li, Yingying Yue, Xiaoyun Liu, Suzhen Chen, Tian Shen, Zhi Xu & Yonggui Yuan. (2022) The interaction of P11 methylation and early-life stress impacts the antidepressant response in patients with major depressive disorder. Journal of Affective Disorders 312, pages 128-135.
Crossref
Crossref
Jiwon S. CrowleyMax L. SilversteinMeera ReghunathanAmanda A. Gosman. (2022) Glabellar Botulinum Toxin Injection Improves Depression Scores: A Systematic Review and Meta-Analysis. Plastic & Reconstructive Surgery 150:1, pages 211e-220e.
Crossref
Crossref
E. A. Proshina, A. V. Bocharov, A. N. Savostyanov & G. G. Knyazev. (2022) Studies of the 5-HTTLPR Serotonin Transporter Polymorphism (literature review). Neuroscience and Behavioral Physiology 52:6, pages 899-909.
Crossref
Crossref
G Pineau, E Jean, L Romo, F Villemain, D Poupon & P Gorwood. (2022) Skin conductance while facing emotional pictures at day 7 helps predicting antidepressant response at three months in patients with a major depressive episode. Psychiatry Research 309, pages 114401.
Crossref
Crossref
Young Sup Woo, Won-Myong Bahk, Jeong Seok Seo, Young-Min Park, Won Kim, Jong-Hyun Jeong, Se-Hoon Shim, Jung Goo Lee, Seung-Ho Jang, Chan-Mo Yang, Sheng-Min Wang, Myung Hun Jung, Hyung Mo Sung, Il Han Choo, Bo-Hyun Yoon, Sang-Yeol Lee, Duk-In Jon & Kyung Joon Min. (2022) The Korean Medication Algorithm Project for Depressive Disorder 2021: Comparisons with Other Treatment Guidelines. Clinical Psychopharmacology and Neuroscience 20:1, pages 37-50.
Crossref
Crossref
Chiara Gastaldon, Pier Francesco Laurenzi, Georgios Schoretsanitis, Davide Papola, Ioana Alina Cristea, Florian Naudet, Giovanni Ostuzzi & Corrado Barbui. (2022) Esketamine for treatment-resistant depression in adults. Cochrane Database of Systematic Reviews 2022:1.
Crossref
Crossref
Rhoda Schuling, Marloes J. Huijbers, Hiske van Ravesteijn, Willem Kuyken & Anne E. M. Speckens. (2021) Mindfulness-Based Compassionate Living (MBCL): a Qualitative Study into the Added Value of Compassion in Recurrent Depression. Mindfulness 12:9, pages 2196-2206.
Crossref
Crossref
Nirmal Raj Marasine, Sabina Sankhi, Rajendra Lamichhane, Nabin Raj Marasini & Nim Bahadur Dangi. (2021) Use of Antidepressants among Patients Diagnosed with Depression: A Scoping Review. BioMed Research International 2021, pages 1-8.
Crossref
Crossref
Silviya Ralovska, Ivan Koychev, Franco De Crescenzo, Petar Marinov & Andrea Cipriani. (2021) Brexpiprazole versus placebo or other antidepressive agents for treating depression. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Antonio Inserra, Danilo De Gregorio & Gabriella Gobbi. (2020) Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms. Pharmacological Reviews 73:1, pages 202-277.
Crossref
Crossref
Julia Carolin Stingl. 2021. Principles of Translational Science in Medicine. Principles of Translational Science in Medicine
71
83
.
Rachael W Taylor, Lindsey Marwood, Emanuella Oprea, Valeria DeAngel, Sarah Mather, Beatrice Valentini, Roland Zahn, Allan H Young & Anthony J Cleare. (2020) Pharmacological Augmentation in Unipolar Depression: A Guide to the Guidelines. International Journal of Neuropsychopharmacology 23:9, pages 587-625.
Crossref
Crossref
Ju-Wan Kim, Robert Stewart, Seung-Ji Kang, Sook-In Jung, Sung-Wan Kim & Jae-Min Kim. (2020) Telephone based Interventions for Psychological Problems in Hospital Isolated Patients with COVID-19. Clinical Psychopharmacology and Neuroscience 18:4, pages 616-620.
Crossref
Crossref
Tian Shen, Xingyu Li, Lei Chen, Zimu Chen, Tingting Tan, Tiantian Hua, Bingwei Chen, Yonggui Yuan, Zhijun Zhang, Liz Kuney & Zhi Xu. (2020) The relationship of tryptophan hydroxylase-2 methylation to early-life stress and its impact on short-term antidepressant treatment response. Journal of Affective Disorders 276, pages 850-858.
Crossref
Crossref
D. Driot, J. Nguyen-Soenen, M. Costes, M. Pomier, J. Birebent, S. Oustric & J. Dupouy. (2020) Prise en charge de la dépression de l’enfant et l’adolescent en soins premiers : une métarevue systématique de la littérature. L'Encéphale 46:1, pages 41-54.
Crossref
Crossref
Yusuke Ogawa, Nozomi Takeshima, Yu Hayasaka, Aran Tajika, Norio Watanabe, David Streiner & Toshi A Furukawa. (2019) Antidepressants plus benzodiazepines for adults with major depression. Cochrane Database of Systematic Reviews.
Crossref
Crossref
. 2019. Therapie psychischer Erkrankungen. Therapie psychischer Erkrankungen
1
119
.
Peipei Wang, Cuizhen Zhang, Qinyu Lv, Chenxi Bao, Hong Sun, Guo Ma, Yiru Fang, Zhenghui Yi & Weimin Cai. (2018) Association of DNA methylation in BDNF with escitalopram treatment response in depressed Chinese Han patients. European Journal of Clinical Pharmacology 74:8, pages 1011-1020.
Crossref
Crossref
Yusuke Ogawa, Toshi A. Furukawa, Nozomi Takeshima, Yu Hayasaka, Lauren Z. Atkinson, Shiro Tanaka, Andrea Cipriani & Georgia Salanti. (2018) Efficacy of antidepressants over placebo is similar in two-armed versus three-armed or more-armed randomized placebo-controlled trials. International Clinical Psychopharmacology 33:2, pages 66-72.
Crossref
Crossref
Peipei Wang, Qinyu Lv, Yemeng Mao, Cuizhen Zhang, Chenxi Bao, Hong Sun, Hanmei Chen, Zhenghui Yi, Weimin Cai & Yiru Fang. (2018) HTR1A/1B DNA methylation may predict escitalopram treatment response in depressed Chinese Han patients. Journal of Affective Disorders 228, pages 222-228.
Crossref
Crossref
Richard Musil, Florian Seemüller, Sebastian Meyer, Ilja Spellmann, Mazda Adli, Michael Bauer, Klaus-Thomas Kronmüller, Peter Brieger, Gerd Laux, Wolfram Bender, Isabella Heuser, Robert Fisher, Wolfgang Gaebel, Rebecca Schennach, Hans-Jürgen Möller & Michael Riedel. (2018) Subtypes of depression and their overlap in a naturalistic inpatient sample of major depressive disorder. International Journal of Methods in Psychiatric Research 27:1, pages e1569.
Crossref
Crossref
Yves de Roten, Gilles Ambresin, Fabrice Herrera, Sylfa Fassassi, Nicolas Fournier, Martin Preisig & Jean-Nicolas Despland. (2017) Efficacy of an adjunctive brief psychodynamic psychotherapy to usual inpatient treatment of depression: Results of a randomized controlled trial. Journal of Affective Disorders 209, pages 105-113.
Crossref
Crossref
. 2017. Therapie psychischer Erkrankungen. Therapie psychischer Erkrankungen
1
111
.
Gerd Laux. 2017. Altersdepression. Altersdepression
97
119
.
Gerd Laux. 2017. Psychiatrie, Psychosomatik, Psychotherapie. Psychiatrie, Psychosomatik, Psychotherapie
1711
1817
.
Rossella Snenghi & Alessandro Amagliani. 2017. P5 Medicine and Justice. P5 Medicine and Justice
486
499
.
Sheila Hardy, Lorraine Bastick, Alex O'Neill-Kerr, Priyadharshini Sabesan, Sudheer Lankappa & Lena Palaniyappan. (2018) Transcranial magnetic stimulation in clinical practice. BJPsych Advances 22:6, pages 373-379.
Crossref
Crossref
José L. Carrasco, Susan G. Kornstein, Roger S. McIntyre, Rana Fayyad, Rita Prieto, Maribel Salas, Joan Mackell & Matthieu Boucher. (2016) An integrated analysis of the efficacy and safety of desvenlafaxine in the treatment of major depressive disorder. International Clinical Psychopharmacology 31:3, pages 134-146.
Crossref
Crossref
David Martín-Hernández, Álvaro G. Bris, Karina S. MacDowell, Borja García-Bueno, José L.M. Madrigal, Juan C. Leza & Javier R. Caso. (2016) Modulation of the antioxidant nuclear factor (erythroid 2-derived)-like 2 pathway by antidepressants in rats. Neuropharmacology 103, pages 79-91.
Crossref
Crossref
Rene Soria-Saucedo, Susan V. Eisen, Howard J. Cabral & Lewis E. Kazis. (2016) Receipt of pharmacotherapy and psychotherapy among a nationally representative US sample of privately insured adults with depression: associations with insurance plan arrangements and provider specialty. Journal of Pharmaceutical Health Services Research 7:1, pages 53-62.
Crossref
Crossref
Gerd Laux. 2016. Psychiatrie, Psychosomatik, Psychotherapie. Psychiatrie, Psychosomatik, Psychotherapie
1
107
.
Healy Smith & Gregory Thorkelson. 2015. Integrative Therapies for Depression. Integrative Therapies for Depression
379
394
.
Gin S Malhi, Darryl Bassett, Philip Boyce, Richard Bryant, Paul B Fitzgerald, Kristina Fritz, Malcolm Hopwood, Bill Lyndon, Roger Mulder, Greg Murray, Richard Porter & Ajeet B Singh. (2015) Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Australian & New Zealand Journal of Psychiatry 49:12, pages 1087-1206.
Crossref
Crossref
Janaina A. Simplicio, Leonardo B. Resstel, Daniela P.C. Tirapelli, Pedro D'Orléans-Juste & Carlos R. Tirapelli. (2015) Contribution of oxidative stress and prostanoids in endothelial dysfunction induced by chronic fluoxetine treatment. Vascular Pharmacology 73, pages 124-137.
Crossref
Crossref
P. Gorwood, K. Demyttenare, G. Vaiva, E. Corruble, P.M. Llorca, F. Bayle & P. Courtet. (2015) An increase in joy after two weeks is more specific of later antidepressant response than a decrease in sadness. Journal of Affective Disorders 185, pages 97-103.
Crossref
Crossref
Ai Leng Khoo, Hui Jun Zhou, Monica Teng, Liang Lin, Ying Jiao Zhao, Lay Beng Soh, Yee Ming Mok, Boon Peng Lim & Kok Peng Gwee. (2015) Network Meta-Analysis and Cost-Effectiveness Analysis of New Generation Antidepressants. CNS Drugs 29:8, pages 695-712.
Crossref
Crossref
Dean F. MacKinnon. 2015. Psychiatry. Psychiatry
902
965
.
Changsu HanSheng-Min WangSoo-Jung LeeTae-Youn JunChi-Un Pae. (2015) Optimizing the Use of Aripiprazole Augmentation in the Treatment of Major Depressive Disorder: From Clinical Trials to Clinical Practice. Chonnam Medical Journal 51:2, pages 66.
Crossref
Crossref
I. V. Damulin & I. A. Suvorova. (2015) The current concept of augmentation of treatment efficeincy with antidepressant medication. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 115:3, pages 106.
Crossref
Crossref
Johannes Beck, Nicole Bruni, Serge Brand & Edith Holsboer-Trachsler. (2015) Repeated Cortisol Awakening Response as Predictor of Antidepressant Treatment Outcome with Duloxetine. Neuropsychobiology 71:2, pages 97-102.
Crossref
Crossref
Xinyu Zhou, Bin Qin, Cinzia Del Giovane, Junxi Pan, Salvatore Gentile, Yiyun Liu, Xinghui Lan, Jia Yu & Peng Xie. (2015) Efficacy and tolerability of antidepressants in the treatment of adolescents and young adults with depression and substance use disorders: a systematic review and meta-analysis. Addiction 110:1, pages 38-48.
Crossref
Crossref
Bernhard Luscher & Thomas Fuchs. 2015. Diversity and Functions of GABA Receptors: A Tribute to Hanns Möhler, Part B. Diversity and Functions of GABA Receptors: A Tribute to Hanns Möhler, Part B
97
144
.
. 2015. Therapie Psychischer Erkrankungen. Therapie Psychischer Erkrankungen
e1
e96
.
Julia Stingl. 2015. Principles of Translational Science in Medicine. Principles of Translational Science in Medicine
59
73
.
Fayçal Mouaffak, Franz Hozer, Olivia Delomel & Patrick Hardy. (2014) Adding to Antidepressant Augmentation. Journal of Clinical Psychopharmacology 34:6, pages 770.
Crossref
Crossref
Elizabeth Brunner, Mauricio Tohen, Olawale Osuntokun, John Landry & Michael E Thase. (2014) Efficacy and Safety of Olanzapine/Fluoxetine Combination vs Fluoxetine Monotherapy Following Successful Combination Therapy of Treatment-Resistant Major Depressive Disorder. Neuropsychopharmacology 39:11, pages 2549-2559.
Crossref
Crossref
X.J. Wen, L.M. Wang, Z.L. Liu, A. Huang, Y.Y. Liu & J.Y. Hu. (2014) Meta-analysis on the efficacy and tolerability of the augmentation of antidepressants with atypical antipsychotics in patients with major depressive disorder. Brazilian Journal of Medical and Biological Research 47:7, pages 605-616.
Crossref
Crossref
Juanjuan Ren, Hui Li, Lena Palaniyappan, Hongmei Liu, Jijun Wang, Chunbo Li & Paolo Maria Rossini. (2014) Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for major depression: A systematic review and meta-analysis. Progress in Neuro-Psychopharmacology and Biological Psychiatry 51, pages 181-189.
Crossref
Crossref
William V. Bobo, Richard A. EpsteinJr.Jr., Rachel M. Hayes, Richard C. Shelton, Tina V. Hartert, Ed Mitchel, Jeff Horner & Pingsheng Wu. (2013) The effect of regulatory advisories on maternal antidepressant prescribing, 1995–2007: an interrupted time series study of 228,876 pregnancies. Archives of Women's Mental Health 17:1, pages 17-26.
Crossref
Crossref
Chi-Un PaeHo-Jun SeoBoung Chul LeeJeong-Ho SeokHong Jin JeonJong-Woo PaikKyung-Phil KwakByung-Joo HamChangsu HanSoo-Jung Lee. (2014) A Meta-Analysis Comparing Open-Label versus Placebo-Controlled Clinical Trials for Aripiprazole Augmentation in the Treatment of Major Depressive Disorder: Lessons and Promises. Psychiatry Investigation 11:4, pages 371.
Crossref
Crossref
. 2014. Therapie Psychischer Erkrankungen. Therapie Psychischer Erkrankungen
1
91
.
Andrea Cipriani, Francesca Girlanda, Emilia Agrimi, Andrea Barichello, Rossella Beneduce, Irene Bighelli, Giulia Bisoffi, Alfredo Bisogno, Paola Bortolaso, Marianna Boso, Carmela Calandra, Liliana Cascone, Caterina Corbascio, Vincenzo Fricchione Parise, Francesco Gardellin, Daniele Gennaro, Batul Hanife, Camilla Lintas, Marina Lorusso, Chiara Luchetta, Claudio Lucii, Francesco Cernuto, Fiorella Tozzi, Alessandra Marsilio, Francesca Maio, Chiara Mattei, Daniele Moretti, Maria Grazia Appino, Michela Nosè, Guglielmo Occhionero, Duccio Papanti, Damiano Pecile, Marianna Purgato, Davide Prestia, Francesco Restaino, Tiziana Sciarma, Alessandra Ruberto, Stefania Strizzolo, Stefania Tamborini, Orlando Todarello, Simona Ziero, Spyridon Zotos & Corrado Barbui. (2013) Effectiveness of lithium in subjects with treatment-resistant depression and suicide risk: a protocol for a randomised, independent, pragmatic, multicentre, parallel-group, superiority clinical trial. BMC Psychiatry 13:1.
Crossref
Crossref
Tamás Treuer, Chia-Yih Liu, Gerardo Salazar, Ronnachai Kongsakon, Fujun Jia, Hussain Habil, Min-Soo Lee, Amanda Lowry & Héctor Dueñas. (2013) Use of antidepressants in the treatment of depression in Asia: Guidelines, clinical evidence, and experience revisited. Asia-Pacific Psychiatry 5:4, pages 219-230.
Crossref
Crossref
Kenneth I. Shulman, Nathan Herrmann & Scott E. Walker. (2013) Current Place of Monoamine Oxidase Inhibitors in the Treatment of Depression. CNS Drugs 27:10, pages 789-797.
Crossref
Crossref
P. Gorwood, F. Bayle, G. Vaiva, P. Courtet, E. Corruble & P.-M. Llorca. (2020) Is it worth assessing progress as early as week 2 to adapt antidepressive treatment strategy? Results from a study on agomelatine and a global meta-analysis. European Psychiatry 28:6, pages 362-371.
Crossref
Crossref
Massimiliano Buoli, Alice Caldiroli & Alfredo Carlo Altamura. (2013) Psychotic versus non-psychotic major depressive disorder: A comparative naturalistic study. Asian Journal of Psychiatry 6:4, pages 333-337.
Crossref
Crossref
Richard Musil, Peter Zill, Florian Seemüller, Brigitta Bondy, Michael Obermeier, Ilja Spellmann, Wolfram Bender, Mazda Adli, Isabella Heuser, Joachim Zeiler, Wolfgang Gaebel, Wolfgang Maier, Marcella Rietschel, Dan Rujescu, Rebecca Schennach, Hans-Jürgen Möller & Michael Riedel. (2012) No influence of brain-derived neurotrophic factor (BDNF) polymorphisms on treatment response in a naturalistic sample of patients with major depression. European Archives of Psychiatry and Clinical Neuroscience 263:5, pages 405-412.
Crossref
Crossref
Anthony J. Rothschild. (2013) Challenges in the Treatment of Major Depressive Disorder With Psychotic Features. Schizophrenia Bulletin 39:4, pages 787-796.
Crossref
Crossref
Richard Musil, Peter Zill, Florian Seemüller, Brigitta Bondy, Sebastian Meyer, Ilja Spellmann, Wolfram Bender, Mazda Adli, Isabella Heuser, Robert Fisher, Wolfgang Gaebel, Wolfgang Maier, Marcella Rietschel, Dan Rujescu, Rebecca Schennach, Hans-Jürgen Möller & Michael Riedel. (2013) Genetics of emergent suicidality during antidepressive treatment—Data from a naturalistic study on a large sample of inpatients with a major depressive episode. European Neuropsychopharmacology 23:7, pages 663-674.
Crossref
Crossref
Rasmus W. Licht. (2013) Is it possible to evaluate true prophylactic efficacy of antidepressants in severely ill patients with recurrent depression? Lessons from a placebo-controlled trial. The fifth trial of the Danish University Antidepressant Group (DUAG-5). Journal of Affective Disorders 148:2-3, pages 286-290.
Crossref
Crossref
Daniela Solomon, Jon Adams & Nicholas Graves. (2013) Economic evaluation of St. John's wort (Hypericum perforatum) for the treatment of mild to moderate depression. Journal of Affective Disorders 148:2-3, pages 228-234.
Crossref
Crossref
Chi-Un Pae & Ashwin A. Patkar. (2013) Clinical Issues in Use of Atypical Antipsychotics for Depressed Patients. CNS Drugs 27:S1, pages 39-45.
Crossref
Crossref
Siegfried Kasper & Stuart MontgomeryRobert Haußmann & Michael Bauer. 2013. Treatment‐resistant Depression. Treatment‐resistant Depression
129
157
.
Siegfried Kasper & Stuart MontgomeryStuart Montgomery. 2013. Treatment‐resistant Depression. Treatment‐resistant Depression
91
105
.
N. Dantchev, S. Tcherny-Lessenot, H. Picard, L. Baraille & D. Quail. (2013) Résultats de la cohorte française de l’étude observationnelle européenne FINDER : qualité de vie de patients traités par antidépresseurs. L'Encéphale 39:2, pages 101-108.
Crossref
Crossref
Sarah Yates, Eleanor Smith, Hamid A Alhaj & R Hamish McAllister-Williams. (2013) Future perspectives on the pharmacological management of depression. Clinical Investigation 3:2, pages 137-151.
Crossref
Crossref
Mengjia Pu, Zhijun ZhangZhi Xu, Yanyan Shi, Leiyu Geng, Yonggui Yuan, Xiangrong Zhang & Gavin P Reynolds. (2013) Influence of genetic polymorphisms in the glutamatergic and GABAergic systems and their interactions with environmental stressors on antidepressant response. Pharmacogenomics 14:3, pages 277-288.
Crossref
Crossref
Anne Katrine K. Leadholm, Anthony J. Rothschild, Willem A. Nolen, Per Bech, Povl Munk-Jørgensen & Søren Dinesen Østergaard. (2013) The treatment of psychotic depression: Is there consensus among guidelines and psychiatrists?. Journal of Affective Disorders 145:2, pages 214-220.
Crossref
Crossref
R Lanzenberger, P Baldinger, A Hahn, J Ungersboeck, M Mitterhauser, D Winkler, Z Micskei, P Stein, G Karanikas, W Wadsak, S Kasper & R Frey. (2012) Global decrease of serotonin-1A receptor binding after electroconvulsive therapy in major depression measured by PET. Molecular Psychiatry 18:1, pages 93-100.
Crossref
Crossref
J. John Mann, Steven P. Roose & Patrick J. McGrath. 2013. Clinical Handbook for the Management of Mood Disorders. Clinical Handbook for the Management of Mood Disorders
37
58
.
K. Leopold, S. Priebe & M. Bauer. 2013. Posttraumatische Belastungsstörungen. Posttraumatische Belastungsstörungen
297
307
.
Gilles Ambresin, Jean-Nicolas Despland, Martin Preisig & Yves de Roten. (2012) Efficacy of an adjunctive brief psychodynamic psychotherapy to usual inpatient treatment of depression: rationale and design of a randomized controlled trial. BMC Psychiatry 12:1.
Crossref
Crossref
Maya Schwartz-Lifshitz, Gil Zalsman, Lucas Giner & Maria A. Oquendo. (2012) Can We Really Prevent Suicide?. Current Psychiatry Reports 14:6, pages 624-633.
Crossref
Crossref
R Belzeaux, A Bergon, V Jeanjean, B Loriod, C Formisano-Tréziny, L Verrier, A Loundou, K Baumstarck-Barrau, L Boyer, V Gall, J Gabert, C Nguyen, J-M Azorin, J Naudin & E C Ibrahim. (2012) Responder and nonresponder patients exhibit different peripheral transcriptional signatures during major depressive episode. Translational Psychiatry 2:11, pages e185-e185.
Crossref
Crossref
Hans-Jürgen Möller. (2011) How close is evidence to truth in evidence-based treatment of mental disorders?. European Archives of Psychiatry and Clinical Neuroscience 262:4, pages 277-289.
Crossref
Crossref
Ying-Jay Liou, Chien-Hsiun Chen, Chih-Ya Cheng, Shiow-Yi Chen, Tai-Jui Chen, Younger W-Y Yu, Fang-Shin Nian, Shih-Jen Tsai & Chen-Jee Hong. (2012) Convergent Evidence from Mouse and Human Studies Suggests the Involvement of Zinc Finger Protein 326 Gene in Antidepressant Treatment Response. PLoS ONE 7:5, pages e32984.
Crossref
Crossref
Thomas E Schlaepfer, Hans Ågren, Palmiero Monteleone, Cristobal Gasto, William Pitchot, Frederick Rouillon, David J Nutt & Siegfried Kasper. (2012) The hidden third: improving outcome in treatment-resistant depression. Journal of Psychopharmacology 26:5, pages 587-602.
Crossref
Crossref
Hanne Vibe Hansen, Ellen Margrethe Christensen, Henrik Dam, Christian Gluud, Jørn Wetterslev & Lars Vedel Kessing. (2012) The Effects of Centralised and Specialised Intervention in the Early Course of Severe Unipolar Depressive Disorder: A Randomised Clinical Trial. PLoS ONE 7:3, pages e32950.
Crossref
Crossref
Zhi Xu, Zhijun Zhang, Yanyan Shi, Mengjia Pu, Yonggui Yuan, Xiangrong Zhang, Lingjiang Li & Gavin P Reynolds. (2011) Influence and interaction of genetic polymorphisms in the serotonin system and life stress on antidepressant drug response. Journal of Psychopharmacology 26:3, pages 349-359.
Crossref
Crossref
H.-J. Möller, I. Bitter, J. Bobes, K. Fountoulakis, C. Höschl & S. Kasper. (2020) Position statement of the European Psychiatric Association (EPA) on the value of antidepressants in the treatment of unipolar depression. European Psychiatry 27:2, pages 114-128.
Crossref
Crossref
Amy Cheung, Carolyn Dewa, Erin E. Michalak, Gina Browne, Anthony Levitt, Robert D. Levitan, Murray W. Enns, Rachel L. Morehouse & Raymond W. Lam. (2012) Direct Health Care Costs of Treating Seasonal Affective Disorder: A Comparison of Light Therapy and Fluoxetine. Depression Research and Treatment 2012, pages 1-5.
Crossref
Crossref
Benjamas Prukkanone, Theo Vos, Melanie Bertram & Stephen Lim. (2012) Cost-Effectiveness Analysis for Antidepressants and Cognitive Behavioral Therapy for Major Depression in Thailand. Value in Health 15:1, pages S3-S8.
Crossref
Crossref
Raymond W. Lam. (2012) Onset, time course and trajectories of improvement with antidepressants. European Neuropsychopharmacology 22, pages S492-S498.
Crossref
Crossref
J.-P. Olié. 2012. Manuel de psychiatrie. Manuel de psychiatrie
571
630
.
Natascha Schwertfeger, Francesca Regen, Armin Szegedi & Otto Benkert. 2012. Handbuch der Psychopharmakotherapie. Handbuch der Psychopharmakotherapie
961
991
.
Edith Holsboer-Trachsler & Florian Holsboer. 2012. Handbuch der Psychopharmakotherapie. Handbuch der Psychopharmakotherapie
589
628
.
Lars Vedel Kessing, Hanne Vibe Hansen, Ellen Margrethe Christensen, Henrik Dam, Christian Gluud & Jørn Wetterslev. (2011) The effects of centralised and specialised combined pharmacological and psychological intervention compared with decentralised and non-specialised treatment in the early course of severe unipolar and bipolar affective disorders - design of two randomised clinical trials. Trials 12:1.
Crossref
Crossref
Bernardo Dell’Osso, M. Carlotta Palazzo, Lucio Oldani & A. Carlo Altamura. (2011) The Noradrenergic Action in Antidepressant Treatments: Pharmacological and Clinical Aspects. CNS Neuroscience & Therapeutics 17:6, pages 723-732.
Crossref
Crossref
Shinichiro Nakajima, Hiroyuki Uchida, Takefumi Suzuki, Koichiro Watanabe, Jinichi Hirano, Tatsuhiko Yagihashi, Hiroyoshi Takeuchi, Takayuki Abe, Haruo Kashima & Masaru Mimura. (2011) Is switching antidepressants following early nonresponse more beneficial in acute-phase treatment of depression?: A randomized open-label trial. Progress in Neuro-Psychopharmacology and Biological Psychiatry 35:8, pages 1983-1989.
Crossref
Crossref
P.-M. Llorca, T. Charpeaud, A. Nourry & L. Samalin. (2011) Les apports de « l’Evidence-Based Medicine » (médecine basée sur les preuves) ou comment optimiser la prise en charge de l’épisode dépressif majeur. L'Encéphale 37:6, pages 457-465.
Crossref
Crossref
Roland Ricken, Katja Wiethoff, Thomas Reinhold, Kathrin Schietsch, Thomas Stamm, Julia Kiermeir, Peter Neu, Andreas Heinz, Michael Bauer & Mazda Adli. (2011) Algorithm-guided treatment of depression reduces treatment costs — Results from the randomized controlled German Algorithm Project (GAPII). Journal of Affective Disorders 134:1-3, pages 249-256.
Crossref
Crossref
Ju-Wei Hsu, Tung-Ping Su, Chen-Ying Huang, Ying-Sheue Chen & Yuan-Hwa Chou. (2011) Faster Onset of Antidepressant Effects of Citalopram Compared With Sertraline in Drug-Naïve First-Episode Major Depressive Disorder in a Chinese Population. Journal of Clinical Psychopharmacology 31:5, pages 577-581.
Crossref
Crossref
Zhi Xu, Zhijun Zhang, Yanyan Shi, Mengjia Pu, Yonggui Yuan, Xiangrong Zhang & Lingjiang Li. (2011) Influence and interaction of genetic polymorphisms in catecholamine neurotransmitter systems and early life stress on antidepressant drug response. Journal of Affective Disorders 133:1-2, pages 165-173.
Crossref
Crossref
A. Schosser, D. Gaysina, S. Cohen‐Woods, E. Domenici, J. Perry, F. Tozzi, A. Korszun, C. Gunasinghe, J. Gray, L. Jones, E.B. Binder, F. Holsboer, N. Craddock, M.J. Owen, I.W. Craig, A.E. Farmer, P. Muglia & P. McGuffin. (2011) A follow‐up case–control association study of tractable (druggable) genes in recurrent major depression. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 156:6, pages 640-650.
Crossref
Crossref
Mark Haddad & Norman Young. (2011) Understanding the use of antidepressants. Practice Nursing 22:7, pages 347-352.
Crossref
Crossref
F Mamdani, M T Berlim, M-M Beaulieu, A Labbe, C Merette & G Turecki. (2011) Gene expression biomarkers of response to citalopram treatment in major depressive disorder. Translational Psychiatry 1:6, pages e13-e13.
Crossref
Crossref
B Luscher, Q Shen & N Sahir. (2010) The GABAergic deficit hypothesis of major depressive disorder. Molecular Psychiatry 16:4, pages 383-406.
Crossref
Crossref
Shuken Boku, Takeshi Inoue, Hiroshi Honma, Shigehiro Matsubara, Shin Nakagawa & Tsukasa Koyama. (2011) Olanzapine augmentation of milnacipran for stage 2 treatment‐resistant major depression: an open study. Human Psychopharmacology: Clinical and Experimental 26:3, pages 237-241.
Crossref
Crossref
Peter Riederer & Gerd Laux. (2011) MAO-inhibitors in Parkinson's Disease. Experimental Neurobiology 20:1, pages 1-17.
Crossref
Crossref
Takeshi Inoue, Tomohiro Abekawa, Shin Nakagawa, Katsuji Suzuki, Teruaki Tanaka, Yuji Kitaichi, Shuken Boku, Yasuya Nakato, Hiroyuki Toda & Tsukasa Koyama. (2011) Long-term naturalistic follow-up of lithium augmentation: Relevance to bipolarity. Journal of Affective Disorders 129:1-3, pages 64-67.
Crossref
Crossref
Chi-Un Pae, Andy Forbes & Ashwin A. Patkar. (2011) Aripiprazole as Adjunctive Therapy for Patients with Major Depressive Disorder. CNS Drugs 25:2, pages 109-127.
Crossref
Crossref
Peter Kenneth Gillman. (2011) Advances Pertaining to the Pharmacology and Interactions of Irreversible Nonselective Monoamine Oxidase Inhibitors. Journal of Clinical Psychopharmacology 31:1, pages 66-74.
Crossref
Crossref
Kyung-Yeol BaeSung-Wan KimJae-Min KimIl-Seon ShinJin-Sang YoonSung-Won JungMin-Soo LeeHyeon-Woo YimTae-Youn Jun. (2011) Antidepressant Prescribing Patterns in Korea: Results from the Clinical Research Center for Depression Study. Psychiatry Investigation 8:3, pages 234.
Crossref
Crossref
Andre Russowsky Brunoni, Leandro Valiengo, Alessandra Baccaro, Tamires Araujo Zanao, Janaina Farias de Oliveira, Giselly Pereira Vieira, Viviane Freire Bueno, Alessandra C. Goulart, Paulo Sérgio Boggio, Paulo Andrade Lotufo, Isabela Martins Bensenor & Felipe Fregni. (2011) Sertraline vs. ELectrical Current Therapy for Treating Depression Clinical Trial - SELECT TDCS: Design, rationale and objectives. Contemporary Clinical Trials 32:1, pages 90-98.
Crossref
Crossref
Zhicheng Lin, Juan J. Canales, Thröstur Björgvinsson, Morgane Thomsen, Hong Qu, Qing-Rong Liu, Gonzalo E. Torres & S. Barak Caine. 2011. The Brain as a Drug Target. The Brain as a Drug Target
1
46
.
G. Laux. 2011. Psychiatrie, Psychosomatik, Psychotherapie. Psychiatrie, Psychosomatik, Psychotherapie
1575
1664
.
H.-J. Möller. 2011. Psychiatrie, Psychosomatik, Psychotherapie. Psychiatrie, Psychosomatik, Psychotherapie
1177
1191
.
Takeshi Inoue, Yuji Kitaichi, Takuya Masui, Shin Nakagawa, Shuken Boku, Teruaki Tanaka, Katsuji Suzuki, Yasuya Nakato, Reiko Usui & Tsukasa Koyama. (2010) Pramipexole for stage 2 treatment-resistant major depression: An open study. Progress in Neuro-Psychopharmacology and Biological Psychiatry 34:8, pages 1446-1449.
Crossref
Crossref
P.-M. Llorca. (2010) Qu’apportent les recommandations de pratique clinique en ce qui concerne la prévention des récidives dépressives. L'Encéphale 36, pages S150-S154.
Crossref
Crossref
Yuji Kitaichi, Takeshi Inoue, Shin Nakagawa, Shuken Boku, Aya Kakuta, Takeshi Izumi & Tsukasa Koyama. (2010) Sertraline increases extracellular levels not only of serotonin, but also of dopamine in the nucleus accumbens and striatum of rats. European Journal of Pharmacology 647:1-3, pages 90-96.
Crossref
Crossref
T.C. Baghai, H.J. Möller & S. Nitschmann. (2010) Effektivität der antidepressiven Therapie bei Patienten mit mäßig ausgeprägter depressiver SymptomatikEfficiency of antidepressant therapy for patients with less severe depression. Der Internist 51:11, pages 1456-1458.
Crossref
Crossref
Qiuying Shen, Rachnanjali Lal, Beth A. Luellen, John C. Earnheart, Anne Milasincic Andrews & Bernhard Luscher. (2010) γ-Aminobutyric Acid-Type A Receptor Deficits Cause Hypothalamic-Pituitary-Adrenal Axis Hyperactivity and Antidepressant Drug Sensitivity Reminiscent of Melancholic Forms of Depression. Biological Psychiatry 68:6, pages 512-520.
Crossref
Crossref
Raymond W. Lam, Sara Larsson Lönn & Nicolas Despiégel. (2010) Escitalopram versus serotonin noradrenaline reuptake inhibitors as second step treatment for patients with major depressive disorder: a pooled analysis. International Clinical Psychopharmacology 25:4, pages 199-203.
Crossref
Crossref
H.J. Möller & D. Rujescu. (2020) Pharmacogenetics – genomics and personalized psychiatry. European Psychiatry 25:5, pages 291-293.
Crossref
Crossref
Andrea Cipriani, Teresa La Ferla, Toshi A Furukawa, Alessandra Signoretti, Atsuo Nakagawa, Rachel Churchill, Hugh McGuire & Corrado Barbui. (2010) Sertraline versus other antidepressive agents for depression. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Hans Jürgen Möller. (2010) WFSBP Treatment Guidelines and the problem of evidence grading. Annals of General Psychiatry 9:S1.
Crossref
Crossref
WTCJ Heijnen, WW van den Broek, PGH Mulder & TK Birkenhäger. (2008) Prevalence of trait anxiety in a sample of depressed inpatients and its influence on response to antidepressants. Journal of Psychopharmacology 24:4, pages 559-563.
Crossref
Crossref
T. Bschor & C. Baethge. (2010) No evidence for switching the antidepressant: systematic review and meta-analysis of RCTs of a common therapeutic strategy. Acta Psychiatrica Scandinavica 121:3, pages 174-179.
Crossref
Crossref
Steffen Sinning, Maria Musgaard, Marie Jensen, Kasper Severinsen, Leyla Celik, Heidi Koldsø, Tine Meyer, Mikael Bols, Henrik Helligsø Jensen, Birgit Schiøtt & Ove Wiborg. (2010) Binding and Orientation of Tricyclic Antidepressants within the Central Substrate Site of the Human Serotonin Transporter. Journal of Biological Chemistry 285:11, pages 8363-8374.
Crossref
Crossref
Shinichiro Nakajima, Takefumi Suzuki, Koichiro Watanabe, Haruo Kashima & Hiroyuki Uchida. (2010) Accelerating response to antidepressant treatment in depression: A review and clinical suggestions. Progress in Neuro-Psychopharmacology and Biological Psychiatry 34:2, pages 259-264.
Crossref
Crossref
Hans-Jürgen Möller & Wolfgang Maier. (2009) Evidence-based medicine in psychopharmacotherapy: possibilities, problems and limitations. European Archives of Psychiatry and Clinical Neuroscience 260:1, pages 25-39.
Crossref
Crossref
Fabrice Jollant, Adéla Ionita & Philippe Courtet. 2010. Clinical Trials in Psychopharmacology. Clinical Trials in Psychopharmacology
103
124
.
Ildiko Antal-Zimanyi & Xavier Khawaja. (2009) The Role of Melanin-Concentrating Hormone in Energy Homeostasis and Mood Disorders. Journal of Molecular Neuroscience 39:1-2, pages 86-98.
Crossref
Crossref
Michael Bauer, Andrea Pfennig, Michael Linden, Michael N. Smolka, Peter Neu & Mazda Adli. (2009) Efficacy of an Algorithm-Guided Treatment Compared With Treatment as Usual. Journal of Clinical Psychopharmacology 29:4, pages 327-333.
Crossref
Crossref
Paul Grof & Bruno Müller‐Oerlinghausen. (2009) A critical appraisal of lithium’s efficacy and effectiveness: the last 60 years. Bipolar Disorders 11:s2, pages 10-19.
Crossref
Crossref
Siegfried Kasper, Julia Sacher, Nikolas Klein, Nilufar Mossaheb, Trawat Attarbaschi-Steiner, Rupert Lanzenberger, Christoph Spindelegger, Susanne Asenbaum, Alexander Holik & Robert Dudczak. (2009) Differences in the dynamics of serotonin reuptake transporter occupancy may explain superior clinical efficacy of escitalopram versus citalopram. International Clinical Psychopharmacology 24:3, pages 119-125.
Crossref
Crossref
Andrea Cipriani, Teresa La Ferla, Toshi A Furukawa, Alessandra Signoretti, Atsuo Nakagawa, Rachel Churchill, Hugh McGuire & Corrado Barbui. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Andrew F. LeuchterIan A. CookAimee HunterAlex Korb. (2009) Use of Clinical Neurophysiology for the Selection of Medication in the Treatment of Major Depressive Disorder: The State of the Evidence. Clinical EEG and Neuroscience 40:2, pages 78-83.
Crossref
Crossref
Karl RickelsMaria Athanasiou & Carol Reed. (2009) Vilazodone, a novel, dual-acting antidepressant: current status, future promise and potential for individualized treatment of depression. Personalized Medicine 6:2, pages 217-224.
Crossref
Crossref
David G.S. Perahia, Deborah Quail, Durisala Desaiah, Angel L. Montejo & Alan F. Schatzberg. (2009) Switching to duloxetine in selective serotonin reuptake inhibitor non- and partial-responders: Effects on painful physical symptoms of depression. Journal of Psychiatric Research 43:5, pages 512-518.
Crossref
Crossref
Andrea Cipriani, Toshiaki A Furukawa, Georgia Salanti, John R Geddes, Julian PT Higgins, Rachel Churchill, Norio Watanabe, Atsuo Nakagawa, Ichiro M Omori, Hugh McGuire, Michele Tansella & Corrado Barbui. (2009) Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. The Lancet 373:9665, pages 746-758.
Crossref
Crossref
Julia Kirchheiner & Cristina Rodriguez-Antona. (2009) Cytochrome P450 2D6 Genotyping. CNS Drugs 23:3, pages 181-191.
Crossref
Crossref
André F Carvalho, Juliana Raulino Machado & João L Cavalcante. (2009) Augmentation strategies for treatment-resistant depression. Current Opinion in Psychiatry 22:1, pages 7-12.
Crossref
Crossref
P.-M. Llorca, A. Schmitt, M. Mialoux & N. Lefevre. (2009) Usage des traitements par électrochoc en psychiatrie. EMC - Psychiatrie 6:2, pages 1-14.
Crossref
Crossref
Elisabeth Schramm & Michael Bauer. 2009. Therapie psychischer Erkrankungen. Therapie psychischer Erkrankungen
171
197
.
Julia Kirchheiner & Matthias Schwab. 2009. Pharmacology and Therapeutics. Pharmacology and Therapeutics
225
238
.
Martin J. Lohse & Bruno Müller-Oerlinghausen. 2009. Arzneiverordnungs-Report 2009. Arzneiverordnungs-Report 2009
767
810
.
Karolina Leopold, Stefan Priebe & Michael Bauer. 2009. Posttraumatische Belastungsstörungen. Posttraumatische Belastungsstörungen
275
284
.
Thomas Messer & Max SchmaußMax Schmauss & Thomas Messer. 2009. Polypharmazie in der Behandlung psychischer Erkrankungen. Polypharmazie in der Behandlung psychischer Erkrankungen
1
51
.
Angela Seeringer & Julia Kirchheiner. (2008) Pharmacogenetics-Guided Dose Modifications of Antidepressants. Clinics in Laboratory Medicine 28:4, pages 619-626.
Crossref
Crossref
K. DemyttenaereL. Jaspers. (2008) Review: Bupropion and SSRI-induced side effects. Journal of Psychopharmacology 22:7, pages 792-804.
Crossref
Crossref
Koen Demyttenaere, Anke Bonnewyn, Ronny Bruffaerts, Giovanni De Girolamo, Isabelle Gasquet, Viviane Kovess, Josep Maria Haro & Jordi Alonso. (2008) Clinical factors influencing the prescription of antidepressants and benzodiazepines:. Journal of Affective Disorders 110:1-2, pages 84-93.
Crossref
Crossref
Rena Cooper-Kazaz & Bernard Lerer. (2007) Efficacy and safety of triiodothyronine supplementation in patients with major depressive disorder treated with specific serotonin reuptake inhibitors. The International Journal of Neuropsychopharmacology 11:05.
Crossref
Crossref
Georg Nikisch & Aleksander A. Mathé. (2020) CSF monoamine metabolites and neuropeptides in depressed patients before and after electroconvulsive therapy. European Psychiatry 23:5, pages 356-359.
Crossref
Crossref
Mladen Vassilev Tzvetkov, Jürgen Brockmöller, Ivar Roots & Julia Kirchheiner. (2008) Common genetic variations in human brain-specific tryptophan hydroxylase-2 and response to antidepressant treatment. Pharmacogenetics and Genomics 18:6, pages 495-506.
Crossref
Crossref
Michael Bauer, Brigitta U. Monz, Angel L. Montejo, Deborah Quail, Nicolas Dantcheve, Koen Demyttenaere, Ana García-Cebrián, Luigi Grassi, David G.S. Perahia, Catherine Reed & Andre Tylee. (2008) Modelos de prescripción de antidepresivos en Europa: Resultados del estudio de los Factores que Influyen en la Investigación de los Criterios de Valoración de la Depresión (FINDER). European psychiatry (Ed. Española) 15:4, pages 167-175.
Crossref
Crossref
Katja Renner. (2008)
Pharmazeutische Betreuung depressiver Patienten.
Compliance
im Focus
. Pharmazie in unserer Zeit 37:3, pages 242-248.
Crossref
Crossref
Christoph Hiemke. (2008) Individualisierte Therapie mit trizyklischen Antidepressiva. Pharmakogenetik der Depression. Pharmazie in unserer Zeit 37:3, pages 234-240.
Crossref
Crossref
Michael E. ThaseTimothey Denko. (2008) Pharmacotherapy of Mood Disorders. Annual Review of Clinical Psychology 4:1, pages 53-91.
Crossref
Crossref
A Serretti, M Kato & J L Kennedy. (2007) Pharmacogenetic studies in depression: a proposal for methodologic guidelines. The Pharmacogenomics Journal 8:2, pages 90-100.
Crossref
Crossref
Christine Norra, Eric C. Skobel, Marlies Arndt & Patrick Schauerte. (2008) High impact of depression in heart failure: Early diagnosis and treatment options. International Journal of Cardiology 125:2, pages 220-231.
Crossref
Crossref
Stuart A. Montgomery. (2008) The under-recognized role of dopamine in the treatment of major depressive disorder. International Clinical Psychopharmacology 23:2, pages 63-69.
Crossref
Crossref
Christoph Hiemke. (2008) Therapeutic drug monitoring in neuropsychopharmacology: does it hold its promises?. European Archives of Psychiatry and Clinical Neuroscience 258:S1, pages 21-27.
Crossref
Crossref
D Tomalik-Scharte, A Lazar, U Fuhr & J Kirchheiner. (2007) The clinical role of genetic polymorphisms in drug-metabolizing enzymes. The Pharmacogenomics Journal 8:1, pages 4-15.
Crossref
Crossref
Christoph Hiemke. (2008) Clinical utility of drug measurement and pharmacokinetics – therapeutic drug monitoring in psychiatry. European Journal of Clinical Pharmacology 64:2, pages 159-166.
Crossref
Crossref
Michael Bauer, Brigitta U. Monz, Angel L. Montejo, Deborah Quail, Nicolas Dantchev, Koen Demyttenaere, Ana Garcia-Cebrian, Luigi Grassi, David G.S. Perahia, Catherine Reed & Andre Tylee. (2020) Prescribing patterns of antidepressants in Europe: Results from the Factors Influencing Depression Endpoints Research (FINDER) study. European Psychiatry 23:1, pages 66-73.
Crossref
Crossref
Displaying 200 of 275 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list